German orthopedic implant maker Syntellix said today that it’s planning an initial public offering on the Singapore Stock Exchange and named a new CFO.
Syntellix makes screws and pins from a magnesium-based material it developed, called Magnezix, that’s designed to be resorbed and converted into bone over time. Its products are approved in Mexico, Vietnam and Indonesia, Syntellix said.
The Hanover-based company said the IPO was unanimously approved at an April 30 shareholders meeting, authorizing the flotation of 1.5 million shares.
“The company had already successfully mastered and fulfilled important regulatory requirements for the respective IPO in Singapore,” according to a press release.
Syntellis also said it named Amir Ghoreishi as CFO and chief scientific officer, saying he will “play a key role in the further preparations for the intended IPO and, as CSO International, he will also help expedite further international expansion.”
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.